| Ytd | 2.08% | |
| 1y | 36.87% |
| Open | 318.37 | Prev Close | 317.39 | Low | 317.29 | High | 318.37 | Mkt Cap | 12.48B |
| Vol | 84.37K | Avg Vol | 428.62K | EPS | 3.83 | P/E | 82.87 | Forward P/E | 62.89 |
| Beta | 0.70 | Short Ratio | 4.90 | Inst. Own | 87.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-28 | 50-d Avg | 319.77 | 200-d Avg | 313.10 | 1yr Est | 362.54 |
PEN News
When investors think of the health care sector, most imagine the stability of pharmaceutical giants
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation o
Evercore ISI Group analyst Vijay Kumar maintains Penumbra (NYSE:PEN) with a Outperform and lowers
Consolidation wave creates opportunities for patient investors. 8 sectors leading now are health, se
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investo
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
On Friday, 1043 companies hit new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
This morning 97 companies reached new 52-week highs.